Valneva SE (VALN) Total Liabilities (2020 - 2026)

Valneva SE's (VALN) quarterly Total Liabilities came in at $345.7 million in Q1 2026, up 7.07% year-on-year from $322.9 million in Q1 2025, and up 1.49% quarter-over-quarter from $340.7 million in Q4 2025.

Valneva SE (VALN) Total Liabilities (2020 - 2026) Analysis & Trends

Valneva SE has disclosed Total Liabilities across 7 years of filings, most recently posting $345.7 million for Q1 2026.

  • Total Liabilities for Q1 2026 came in at $345.7 million, up 7.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $345.7 million (up 7.07% YoY), and the FY2025 annual result was $340.7 million, changed 0.01% from the prior year.
  • Total Liabilities came in at $345.7 million for Q1 2026 at Valneva SE, up from $340.7 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $706.3 million in Q1 2022 to a low of $322.9 million in Q1 2025.
  • The 5-year median for Total Liabilities is $348.1 million (2025), against an average of $405.4 million.
  • Peak annual rise in Total Liabilities reached 238.66% in 2022, while the deepest fall reached 44.63% in 2022.
  • Valneva SE's Total Liabilities stood at $409.7 million in 2022, then declined by 12.86% to $357.0 million in 2023, then decreased by 4.58% to $340.6 million in 2024, then increased by 0.01% to $340.7 million in 2025, then climbed by 1.49% to $345.7 million in 2026.
  • The last three Total Liabilities figures came in at $345.7 million (Q1 2026), $340.7 million (Q4 2025), and $348.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 1.74 Mn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 15.48 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 16.35 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 731.60 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 19.51 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 10.44 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 943,068.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 7.12 Bn
9 Abivax 94.26 Bn 94.26 Bn - 137.56 Mn
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn 345.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 345.74 Mn
Dec 31, 2025 340.68 Mn
Sep 30, 2025 348.09 Mn
Jun 30, 2025 323.96 Mn
Mar 31, 2025 322.92 Mn
Dec 31, 2024 340.65 Mn
Sep 30, 2024 328.53 Mn
Jun 30, 2024 323.38 Mn
Mar 31, 2024 340.68 Mn
Dec 31, 2023 357.01 Mn
Sep 30, 2023 395.18 Mn
Jun 30, 2023 383.15 Mn
Mar 31, 2023 413.47 Mn
Dec 31, 2022 409.68 Mn
Sep 30, 2022 537.51 Mn
Jun 30, 2022 674.22 Mn
Mar 31, 2022 706.29 Mn
Dec 31, 2021 739.89 Mn
Sep 30, 2021 -387.64 Mn
Dec 31, 2020 443.22 Mn